Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
Report Scope
This report analyzes the global market for radiation therapy products (systems, software and services) and radiopharmaceuticals, in terms of quantitative and qualitative data, to help readers develop assess the market, business/growth strategies, and make informed business decisions regarding radiation therapy products and services and radiopharmaceuticals. BCC Research estimates market data for 2023 (the base year) and forecasts values for 2024 through 2029.
Radiation therapy market segmentation is based on product, technology, techniques, system type, application and region. Radiopharmaceuticals market segmentation is based on product, application, production method and region.
Industry growth drivers, restraints and opportunities in the radiation therapy and radiopharmaceutical market are also discussed. The report also reports on the competitive landscape of radiation therapy products, radiopharmaceutical markets and emerging trends. The latest new products, acquisitions, and collaborations related to the radiation therapy and radiopharmaceutical markets are also covered.
Report Includes
51 data tables and 39 additional tables
An overview of the global market for radiotherapy, radiopharmaceuticals and nuclear medicines
Analysis of global market trends, featuring historical revenue data for 2021-2023, estimated figures for 2024, forecasts for 2025, and projected CAGRs through 2029
Identification of new opportunities, challenges and technological changes in the industry and a market share analysis by segment, product type, technology type, application, production method, and region
Examination of the present and future strategies of companies in the market, including radiopharmaceuticals for both diagnostic and therapeutic purposes
Discussion of the applications for positron emission tomography (PET) and single photon emission computed tomography (SPECT)
Evaluation of market opportunities for external beam radiation therapy, internal radiation therapy and systemic radiotherapy
Analysis of the current market trends and forecast, R&D activity, product launches and regulatory elements
Analysis of the key companies’ market shares, mergers & acquisitions, joint ventures and collaborations
Profiles of the major players in the market, including Accuray Inc., Cardinal Health, Elekta, Novartis AG, and Siemens Healthineers AG
Companies MentionedACCURAY INC.
CARDINAL HEALTH
CURIUM
ELEKTA
GE HEALTHCARE
LANTHEUS
NOVARTIS AG
SIEMENS HEATHNIEERS AG